Yüklüyor......
Risks and benefits of continued aggressive statin therapy
The 3‐hydroxy‐3‐methylglutaryl coenzyme A (HMG‐CoA) reductase inhibitors, or statins, are a well‐tolerated, effective class of medications for the reduction of low‐density lipoprotein cholesterol (LDL‐C) and total cholesterol levels. Extensive data from clinical trials demonstrate that these agents...
Kaydedildi:
| Yayımlandı: | Clin Cardiol |
|---|---|
| Yazar: | |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Wiley Periodicals, Inc.
2007
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6654306/ https://ncbi.nlm.nih.gov/pubmed/12708633 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/clc.4960261503 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|